Influence of diabetes on efficacy of aliskiren, losartan or both on left ventricular mass regression

Influence of diabetes on efficacy of aliskiren, losartan or both on left ventricular mass regression

Hypothesis/Introduction : We investigated whether diabetes modified the effectiveness of renin–angiotensin–aldosterone system (RAAS) inhibition on left ventricular hypertrophy (LVH) regression in hypertensive patients in the Aliskiren in Left Ventricular Hypertrophy (ALLAY) trial. Materials and meth...

Full description

Bibliographic Details
Main Authors: Orly Vardeny, Anne-Catherine Pouleur, Madoka Takeuchi, Evan Appelbaum, Anil Verma, Margaret Prescott, Beverly Smith, Bjorn Dahlof, Scott D Solomon
Format: Article
Language:English
Published: Hindawi - SAGE Publishing 2012-06-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.1177/1470320312437893

Internet

https://doi.org/10.1177/1470320312437893

Similar Items